Alcoa enters the final week of June having shed 12% in five sessions, closing at $55.08 on Tuesday — a month-to-date loss of nearly 23% that has pushed the stock well below every analyst price target on the Street.
The clearest story here is the valuation gap the selloff has opened. The consensus mean price target is $81.64, implying a return of roughly 48% from current levels. That gap is wide enough to matter: UBS upgraded to Buy in late May with an $80 target, Morgan Stanley moved to Overweight in April at $80, and Wells Fargo upgraded to Overweight in early May at $70. The direction of travel from analysts has been uniformly upward since March — JP Morgan moved from Underweight to Neutral, Citigroup raised its Buy target to $76. Every major firm that has published on the name in 2026 has either upgraded or lifted its target. The P/E multiple has contracted to 7.9x over the past month, down from above 10x, and EV/EBITDA has slipped to 4.4x — both near cycle-trough levels that typically attract value buyers in basic materials. EPS momentum factor scores rank in the 82nd–85th percentile, suggesting earnings estimates have been holding up even as the stock has fallen.
The selling is sector-wide, not an AA-specific event. CENX fell 13% on the week — nearly identical to Alcoa's drawdown — while dropped 9% and lost 8%. The metals complex is repricing in unison, driven by macro concerns rather than company fundamentals. That broad context matters: when an entire sector de-rates together, the signal from short interest alone is limited.
Short positioning tells a deliberately calm story against that backdrop. Short interest on AA is just 2.35% of the free float — genuinely low — and it has been falling, down roughly 8% over the past month. The borrow market confirms there is no squeeze dynamic at work: availability is effectively unlimited, with over 260 million shares available to lend against a short position of just 6 million. Cost to borrow is running at 0.40%, essentially the risk-free rate. The ORTEX short score sits at 29.8 and has been drifting lower all week. Bears are not piling in here — if anything, shorts have been covering into the weakness.
Options positioning adds a similarly measured read. The put/call ratio at 0.90 is fractionally below its 20-day average of 0.91, essentially in line with recent norms and a long way from the 52-week defensive extreme of 1.40 seen at the peak of last year's hedging activity. Options traders are not pressing downside protection at an unusual rate, even after a 23% one-month drawdown.
Institutional ownership shows no obvious sign of distress selling from the top of the register. BlackRock held 10.8% of shares as of late May. FMR added nearly 7.9 million shares in the most recent reported period, a substantial accumulation. The insider data is stale — the most recent trades date to February 23 — so no fresh signal there.
Q2 earnings are due July 15. The prior print in April saw the stock fall 6.8% on the day and extend losses to 7.1% over the following five sessions. With the stock now trading at a fraction of consensus targets and the borrow market showing no sign of a new short thesis building, the July 15 print becomes the focal point for whether the gap between $55 and an $80-plus Street view starts to close or widens further.
See the live data behind this article on ORTEX.
Open AA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
